Header cover image
  • Investing Ideas
  • /
  • U.S. Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying

U.S. Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying

Results

1

0 new

Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.

1 companies

Azenta

Market Cap: US$1.4b

Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

AZTA

US$28.75

7D

-7.4%

1Y

-41.5%